Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent's novel radiopharmaceutical therapy to target peritoneal disease in colorectal cancer OSLO, Norway, June 18, 2025 /PRNewswire/ -- Oncoinvent ASA, a clinical-stage radiopharmaceutical company...
Hence then, the article about oncoinvent announces positive final data from phase 1 2a trial of radspherin in patients with colorectal peritoneal metastases was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases )
Also on site :
- Witney Carson Claps Back at ‘DWTS’ Judge Carrie Ann Inaba, Joining Uproar Over Comments on Guillermo Rodriguez: ‘I Said What I Said’
- Tom DeLonge Was in the Crowd When 43,000 Fans Serenaded Him With His Own Song: ‘He Was Definitely in His Feels’
- Disney Cruise Line Offers First Look Inside Disney Believe with New Frozen Dining, Encanto Show, and Themed Lounges